We excluded four genes (SLCO3A1, C10orf11, PTPRJ, and NMNAT1) from further analysis because the direction of association of additional tested SNPs with glioma risk was inconsistent with our hypothesis. The gene discussed is LRMDA; the disease is central nervous system cancer.